LNAI — Lunai Bioworks Share News
0.000.00%
Last trade - 00:00- $1.48m
- $0.76m
- $0.05m
Brief: Renovaro Biosciences Inc - On October 4 Board Increased Size Of Board To Ten Members
Brief: Ai Company Gedicube And Renovaro Biosciences Sign Definitive Agreement To Combine
U.S. STOCKS ON THE MOVE-Mercato, Baytex, Ball Corp
U.S. STOCKS ON THE MOVE-SeaStar, Sigma Lithium, Brinker
Renovaro BioSciences up on merger agreement with GEDi Cube
Brief: Gedi Cube And Renovaro Biosciences Sign Definitive Agreement To Combine
Brief: Enochian Biosciences Inc - On July 7 Received A Deficiency Notice From Nasdaq
Brief: Enochian Biosciences On June 20 Entered Into Purchase Agreement With Lincoln Park Capital Fund
Brief: Enochian Biosciences Says Its Cancer Platform Remains On Track For Trials In Humans Following FDA Review
Brief: Enochian BioSciences Achieves Full Compliance With Nasdaq Filing Requirements
Brief: Enochian Biosciences Achieves Full Compliance With NASDAQ Filing Requirements
Brief: Enochian Biosciences Announces Receipt Of Notice From Nasdaq Regarding Delayed Filing Of Form 10-Q For The Period Ended December 31, 2022
Brief: Nasdaq Notifies Enochian Biosciences That It Would Grant Co To Regain Compliance With Listing Rule
Brief: Enochian Biosciences Announces Receipt Of Notice From Nasdaq Regarding Delayed Filing Of Form 10-Q For The Period Ended September 30, 2022
Brief: Enochian Biosciences Files Complaint Against Serhat Gumrukcu, Others
Brief: Enochian Biosciences Announces Receipt Of Notice From Nasdaq Regarding Delayed Filing Of Annual Report
Brief: Enochian Biosciences Awarded U.S. Patent For Its Oncology Platform
Brief: Enochian Biosciences Inc - Reorganizing And Refocusing On The Most Promising Pipelines
Enochian falls after internal review finds altered, falsified data sets